Bio Essence Corporation
BIOE
$0.19
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 350.92% | 199.81% | 3,828.62% | 101.08% | 127.77% |
| Total Depreciation and Amortization | 103,500.00% | 0.00% | -66.67% | 0.00% | -66.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.31% | -65.22% | -54.49% | -99.24% | -90.76% |
| Change in Net Operating Assets | -428.56% | -475.05% | -52.89% | -49.49% | -8.29% |
| Cash from Operations | -64.42% | -1,478.54% | 193.33% | -47.63% | 996.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -633.58% | 23.99% | 140.48% | 73.26% | 1,561.82% |
| Total Debt Repaid | 268.76% | -31.00% | -889.72% | 18.78% | -82,600.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 93.86% | 1,714.17% | -181.24% | 53.03% | -2,793.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 2,685.71% | -0.35% | 41.38% | -100.00% |